Dr. Dow's current position is as Associate Professor in the Departments of Clinical Sciences and Pathology in the College of Veterinary Medicine at Colorado State University. Dr. Dow formerly was an instructor and research scientist at the National Jewish Medical and Research Center in Denver.
His current major research interests are in immunotherapeutic approaches to the treatment of cancer and chronic infectious diseases. Prior to developing a cancer gene therapy program, his past research has studied animal models of chronic viral infection (feline immunodeficiency virus and feline leukemia virus), as well as the role of CD8+ T cells in immunity to tuberculosis.
Dr. Dow is experienced in the discovery and application of gene therapy to oncologic and immune-mediated diseases and holds patents related to cell regulation with gene therapy. He also has several pending patents, including those that constitute the enabling technology for Juvaris BioTherapeutics, Inc. |